Rationale and Objectives
This multicenter study aimed to explore the feasibility of radiomics based on intra-
and peritumoral regions on preoperative breast cancer contrast-enhanced mammography
(CEM) to predict axillary lymph node (ALN) metastasis.
Materials and Methods
A total of 809 patients with preoperative breast cancer CEM images from two centers
were retrospectively recruited. Least absolute shrinkage and selection operator (LASSO)
regression was used to select radiomics features extracted from CEM images in regions
of the tumor and peritumoral area of five and ten mm as well as construct radiomics
signature. A nomogram, including the optimal radiomics signature and clinicopathological
factors, was then constructed. Nomogram performance was evaluated using AUC and compared
with breast radiologists directly.
Results
In the internal testing set, AUCs of peritumoral signatures decreased when the peritumoral
area increased and signaturetumor + 10mm demonstrated the best performance with an AUC of 0.712. The nomogram incorporating
signaturetumor + 10mm, tumor diameter, progesterone receptor (PR), human epidermal growth factor receptor
2 (HER-2), and CEM-reported lymph node status yielded maximum AUCs of 0.753 and 0.732
in internal and external testing sets, respectively. Moreover, the nomogram outperformed
radiologists and improved diagnostic performance of radiologists.
Conclusion
The nomogram based on CEM intra- and peritumoral regions may provide a noninvasive
auxiliary tool to guide treatment strategy of ALN metastasis in breast cancer.
Key Words
Abbreviations:
ALN (Axillary lymph node), ALND (Axillary lymph node dissection), CEM (Contrast-enhanced mammography), DCA (Decision curve analysis), ER (Estrogen receptor), ICC (Intraclass correlation coefficient), IDI (Integrated discrimination improvement), HER-2 (Human epidermal growth factor receptor), LASSO (Least absolute shrinkage and selection operator), NRI (Net reclassification improvement), PR (Progesterone receptor), SLN (Sentinel lymph node), SLNB (Sentinel lymph node biopsy), VIF (Variance inflation factor)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Academic RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer Statistics, 2021.CA Cancer J Clin. 2021; 71: 7-33
- Breast cancer statistics, 2015: convergence of incidence rates between black and white women.CA Cancer J Clin. 2016; 66: 31-42
- Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.J Magn Reson Imaging. 2019; 49: 131-140
- Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial.JAMA. 2017; 318: 918-926
- Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study.Ann Surg Oncol. 2008; 15: 2533-2541
- Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction.Cancer J. 2008; 14: 216-222
- A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.Breast Cancer Res Treat. 2013; 139: 125-134
- Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update.J Clin Oncol. 2017; 35: 561-564
- Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the american college of surgeons oncology group (alliance) ACOSOG Z0011 randomized trial.Ann Surg. 2016; 264: 413-420
- The sentinel node procedure in breast cancer: nuclear medicine as the starting point.J Nucl Med. 2011; 52: 405-414
- Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.Jpn J Clin Oncol. 2012; 42: 1002-1007
- The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.PLoS One. 2011; 6: e20297
- Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population.Eur J Cancer. 2013; 49: 564-571
- Contrast-enhanced mammography implementation, performance, and use for supplemental breast cancer screening.Radiol Clin North Am. 2021; 59: 113-128
- Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions.J Comput Assist Tomogr. 2019; 43: 245-251
- Contrast-enhanced spectral mammography is comparable to MRI in the assessment of residual breast cancer following neoadjuvant systemic therapy.Ann Surg Oncol. 2018; 25: 1350-1356
- Low-dose, contrast-enhanced mammography compared to contrast-enhanced breast MRI: a feasibility study.J Magn Reson Imaging. 2020; 52: 589-595
- The potential of radiomic-based phenotyping in precision medicine: a review.JAMA Oncol. 2016; 2: 1636-1642
- Radiomics: the bridge between medical imaging and personalized medicine.Nat Rev Clin Oncol. 2017; 14: 749-762
- (18)F-FDG PET-based radiomics model for predicting occult lymph node metastasis in clinical N0 solid lung adenocarcinoma.Quant Imaging Med Surg. 2021; 11: 215-225
- An ultrasound radiomics nomogram for preoperative prediction of central neck lymph node metastasis in papillary thyroid carcinoma.Front Oncol. 2020; 10: 1591
- Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer.JAMA Netw Open. 2020; 3e2028086
- Difference of DCE-MRI parameters at different time points and their predictive value for axillary lymph node metastasis of breast cancer.Acad Radiol. 2022; 29: S79-S86
- Comparison of traditional radiomics, deep learning radiomics and fusion methods for axillary lymph node metastasis prediction in breast cancer.Acad Radiol. 2022; (Online ahead of print)
- Contrast-enhanced spectral mammography-based radiomics nomogram for identifying benign and malignant breast lesions of sub-1 cm.Front Oncol. 2020; 10573630
- Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study.Eur Radiol. 2020; 30: 6732-6739
- Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.Cancer Res. 2007; 67: 2729-2735
- Lymphatic metastasis in the absence of functional intratumor lymphatics.Science. 2002; 296: 1883-1886
- Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.Eur Radiol. 2022; 32: 3207-3219
- Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.Eur Radiol. 2021; 31: 4824-4838
- The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping.Radiology. 2020; 295: 328-338
- A Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.Front Oncol. 2020; 10: 1654
- Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancer.Eur J Radiol. 2021; 134109429
- Can peritumoral radiomics improve the prediction of malignancy of solid pulmonary nodule smaller than 2 cm?.Acad Radiol. 2020; 29 Suppl 2: S47-S52
- Optimizing the peritumoral region size in radiomics analysis for sentinel lymph node status prediction in breast cancer.Acad Radiol. 2020; 29 Suppl 1: S223-S228
- Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.J Magn Reson Imaging. 2020; 51: 615-626
- Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI.Eur Radiol. 2018; 28: 582-591
- Prediction of axillary lymph node metastasis in breast cancer using intra-peritumoral textural transition analysis based on dynamic contrast-enhanced magnetic resonance imaging.Acad Radiol. 2022; 29: S107-S115
- Deep learning vs. radiomics for predicting axillary lymph node metastasis of breast cancer using ultrasound images: don't forget the peritumoral region.Front Oncol. 2020; 10: 53
- Lymph node metastasis prediction from primary breast cancer US images using deep learning.Radiology. 2020; 294: 19-28
- Preoperative ultrasound-based radiomics score can improve the accuracy of the Memorial Sloan Kettering Cancer Center nomogram for predicting sentinel lymph node metastasis in breast cancer.Eur J Radiol. 2021; 135109512
- Ultrasound-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in early-stage invasive breast cancer.Eur J Radiol. 2019; 119108658
- Contrast-enhanced spectral mammography-based radiomics nomogram for the prediction of neoadjuvant chemotherapy-insensitive breast cancers.Front Oncol. 2021; 11605230
- Classification of contrast-enhanced spectral mammography (CESM) images.Int J Comput Assist Radiol Surg. 2019; 14: 249-257
- Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer.Int J Cancer. 2018; 142: 1901-1910
- Prediction of sentinel lymph node metastasis using the platelet-to-lymphocyte ratio in T1 breast cancer.Anticancer Res. 2020; 40: 2343-2349
Article info
Publication history
Published online: April 21, 2023
Accepted:
February 3,
2023
Received in revised form:
February 3,
2023
Received:
November 14,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Published by Elsevier Inc. on behalf of The Association of University Radiologists.